Detail Information of Post-Translational Modifications

General Information of Drug Transporter (DT)
DT ID	DTD0029 Transporter Info
Gene Name	SLCO1A2
Transporter Name	Organic anion transporting polypeptide 1A2
Gene ID	6579
UniProt ID	P46721

Post-Translational Modification of This DT
Overview of SLCO1A2 Modification Sites with Functional and Structural Information
Sequence	M G E T E K R I E T H R I R C L S K L K M F L L A I T C A F V S K T L S G S Y M N S M L T Q I E R Q F N I P T S L V G F I N G S F E I G N L L L I I F V S Y F G T K L H R P I M I G I G C V V M G L G C F L K S L P H F L M N Q Y E Y E S T V S V S G N L S S N S F L C M E N G T Q I L R P T Q D P S E C T K E V K S L M W V Y V L V G N I V R G M G E T P I L P L G I S Y I E D F A K F E N S P L Y I G L V E T G A I I G P L I G L L L A S F C A N V Y V D T G F V N T D D L I I T P T D T R W V G A W W F G F L I C A G V N V L T A I P F F F L P N T L P K E G L E T N A D I I K N E N E D K Q K E E V K K E K Y G I T K D F L P F M K S L S C N P I Y M L F I L V S V I Q F N A F V N M I S F M P K Y L E Q Q Y G I S S S D A I F L M G I Y N L P P I C I G Y I I G G L I M K K F K I T V K Q A A H I G C W L S L L E Y L L Y F L S F L M T C E N S S V V G I N T S Y E G I P Q D L Y V E N D I F A D C N V D C N C P S K I W D P V C G N N G L S Y L S A C L A G C E T S I G T G I N M V F Q N C S C I Q T S G N S S A V L G L C D K G P D C S L M L Q Y F L I L S A M S S F I Y S L A A I P G Y M V L L R C M K S E E K S L G V G L H T F C T R V F A G I P A P I Y F G A L M D S T C L H W G T L K C G E S G A C R I Y D S T T F R Y I Y L G L P A A L R G S S F V P A L I I L I L L R K C H L P G E N A S S G T E L I E T K V K G K E N E C K D I Y Q K S T V L K D D E L K T K L
PTM type	X-Acetylation X-N-glycosylation X-Oxidation X-Phosphorylation X: Amino Acid

Acetylation
Lysine	1 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLCO1A2			[1]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	33
Experimental Method	Co-Immunoprecipitation
Detailed Description	Acetylation at SLCO1A2 Lysine 33 has the potential to affect its expression or activity.
N-glycosylation
Asparagine	6 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Decreasing the membrane localization and transport function of the SLCO1A2			[2]
Role of PTM	Trafficking to Plasma Membrane
Affected Drug/Substrate	Taurocholate	Results for Drug	Decreasing the transport of taurocholate
Modified Residue	Asparagine	Modified Location	62
Modified State	Asparagine to Aspartate substitution
Experimental Method	Co-Immunoprecipitation
Detailed Description	Removal of the N-glycosylation at SLCO1A2 Asparagine 62 (i.e. Asparagine to Aspartate substitution) have been reported to decrease its membrane localization and transport function.
PTM Phenomenon 2	Decreasing the membrane localization and transport function of the SLCO1A2			[2]
Role of PTM	Trafficking to Plasma Membrane
Affected Drug/Substrate	Taurocholate	Results for Drug	Decreasing the transport of taurocholate
Modified Residue	Asparagine	Modified Location	124
Modified State	Asparagine to Aspartate substitution
Experimental Method	Co-Immunoprecipitation
Detailed Description	Removal of the N-glycosylation at SLCO1A2 Asparagine 124 (i.e. Asparagine to Aspartate substitution) have been reported to decrease its membrane localization and transport function.
PTM Phenomenon 3	Decreasing the membrane localization and transport function of the SLCO1A2			[2]
Role of PTM	Trafficking to Plasma Membrane
Affected Drug/Substrate	Taurocholate	Results for Drug	Decreasing the transport of taurocholate
Modified Residue	Asparagine	Modified Location	135
Modified State	Asparagine to Aspartate substitution
Experimental Method	Co-Immunoprecipitation
Detailed Description	Removal of the N-glycosylation at SLCO1A2 Asparagine 135 (i.e. Asparagine to Aspartate substitution) have been reported to decrease its membrane localization and transport function.
PTM Phenomenon 4	Decreasing the membrane localization and transport function of the SLCO1A2			[2]
Role of PTM	Trafficking to Plasma Membrane
Affected Drug/Substrate	Taurocholate	Results for Drug	Decreasing the transport of taurocholate
Modified Residue	Asparagine	Modified Location	492
Modified State	Asparagine to Aspartate substitution
Experimental Method	Co-Immunoprecipitation
Detailed Description	Removal of the N-glycosylation at SLCO1A2 Asparagine 492 (i.e. Asparagine to Aspartate substitution) have been reported to decrease its membrane localization and transport function.
PTM Phenomenon 5	Have the potential to influence SLCO1A2			[3]
Role of PTM	Potential impacts
Modified Residue	Asparagine	Modified Location	412
Experimental Method	Co-Immunoprecipitation
Detailed Description	N-linked Glycosylation at SLCO1A2 Asparagine 412 has the potential to affect its expression or activity.
PTM Phenomenon 6	Have the potential to influence SLCO1A2			[3]
Role of PTM	Potential impacts
Modified Residue	Asparagine	Modified Location	419
Experimental Method	Co-Immunoprecipitation
Detailed Description	N-linked Glycosylation at SLCO1A2 Asparagine 419 has the potential to affect its expression or activity.
Oxidation
Cystine	1 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLCO1A2			[4]
Role of PTM	Potential impacts
Modified Residue	Cystine	Modified Location	500
Experimental Method	Co-Immunoprecipitation
Detailed Description	Oxidation at SLCO1A2 Cystine 500 has the potential to affect its expression or activity.
Phosphorylation
Serine	1 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLCO1A2			[5]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	337
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLCO1A2 Serine 337 has the potential to affect its expression or activity.
Tyrosine	2 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLCO1A2			[6]
Role of PTM	Potential impacts
Modified Residue	Tyrosine	Modified Location	422
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLCO1A2 Tyrosine 422 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence SLCO1A2			[6]
Role of PTM	Potential impacts
Modified Residue	Tyrosine	Modified Location	430
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLCO1A2 Tyrosine 430 has the potential to affect its expression or activity.

References
1	Peripheral autonomic changes accompanying learning and reaction time performance in older people. J Gerontol. 1980 Jan;35(1):57-65.
2	N-glycosylation controls functional activity of Oatp1, an organic anion transporter. Am J Physiol Gastrointest Liver Physiol. 2003 Aug;285(2):G371-81.
3	dbPTM in 2022: an updated database for exploring regulatory networks and functional associations of protein post-translational modifications. Nucleic Acids Res. 2022 Jan 7;50(D1):D471-D479. (ID: SO1A2_HUMAN)
4	Identifying Functional Cysteine Residues in the Mitochondria. ACS Chem Biol. 2017 Apr 21;12(4):947-957.
5	iTRAQ labeling is superior to mTRAQ for quantitative global proteomics and phosphoproteomics. Mol Cell Proteomics. 2012 Jun;11(6):M111.014423.
6	An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome. J Proteomics. 2014 Jan 16;96:253-62.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.

Detail Information of Post-Translational Modifications

Visitor Map

Correspondence